Holen Sie sich die Stockscreener-App
0.772
1.31%
0.01
Handel nachbörslich:
2.58
1.808
+234.20%
Schlusskurs vom Vortag:
$0.762
Offen:
$0.77
24-Stunden-Volumen:
242.08K
Relative Volume:
0.08
Marktkapitalisierung:
$7.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.13M
KGV:
-1.6816
EPS:
-0.4591
Netto-Cashflow:
$-4.60M
1W Leistung:
+7.22%
1M Leistung:
-36.72%
6M Leistung:
-30.45%
1J Leistung:
-52.78%
1-Tages-Spanne:
$0.76
$0.845
1-Wochen-Bereich:
$0.68
$0.845
52-Wochen-Spanne:
$0.63
$1.90
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Firmenname
Pharmacyte Biotech Inc
Sektor
Branche
Telefon
(917) 595.2850
Adresse
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Vergleichen Sie PMCB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.83 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.82 | 418.21M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.30 | 329.86M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
48.05 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
105.25 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Aktie (PMCB) Neueste Nachrichten
How institutional buying supports PharmaCyte Biotech Inc. stock2026 world cup usa national team qualification goalkeepers high defensive line odds analysis preview - Улправда
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Largest borrow rate increases among liquid names - TipRanks
Will PharmaCyte Biotech Inc. stock benefit from infrastructure spending2025 Top Gainers & Weekly Breakout Watchlists - Улправда
Is PharmaCyte Biotech Inc. stock positioned for digital transformation2025 Trading Recap & Free Community Supported Trade Ideas - Улправда
Will PharmaCyte Biotech Inc. stock keep outperforming rivalsLong Setup & AI Forecasted Entry and Exit Points - DonanımHaber
How PharmaCyte Biotech Inc. stock reacts to job market dataJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - Улправда
How sustainable is PharmaCyte Biotech Inc. stock dividend payoutVolume Spike & Weekly Momentum Stock Picks - Улправда
Why PharmaCyte Biotech Inc. stock is a value investor pickShare Buyback & Expert Verified Stock Movement Alerts - Улправда
PharmaCyte Biotech, Inc. SEC 10-Q Report - TradingView — Track All Markets
Movement Recap: How sustainable is PharmaCyte Biotech Inc. stock dividend payoutJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - Улправда
PharmaCyte Biotech delays quarterly report filing - MSN
PharmaCyte Biotech Delays Quarterly Report Filing - TipRanks
PharmaCyte Biotech (PMCB) files notice of late Form 10-Q under Rule 12b-25 - Stock Titan
Dir Walker Surrenders 16,875 Of PharmaCyte Biotech Inc [PMCB] - TradingView — Track All Markets
PharmaCyte Biotech faces NASDAQ non-compliance notice - MSN
Healthy Upside Potential: PharmaCyte Biotech Inc (PMCB) - setenews.com
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Biotech Faces Nasdaq Non-Compliance Notice - TipRanks
PharmaCyte Biotech’s Potential Explored Amidst Market Movements - timothysykes.com
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Why PharmaCyte Biotech Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Down 6.1% – Here’s What Happened - Defense World
Take off with PharmaCyte Biotech Inc (PMCB): Get ready for trading - Setenews
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Is PharmaCyte Biotech Inc a good long term investmentVolatility Adjusted Trading & High Profit Market Ideas - earlytimes.in
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
PharmaCyte Biotech - The Pharma Letter
PharmaCyte Biotech successfully monetizes Femasys stake - The Pharma Letter
Check Out PharmaCyte Biotech Inc (PMCB)’s Trade Data Rather Than the Analysts’ Views - Setenews
A History of Outperforming Analyst Forecasts and Beating the Odds: Clean Energy Technologies Inc (CETY) - Setenews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
PharmaCyte Biotech (PMCB) Stock: Increases Cash and Securities to $20M Strengthening Balance Sheet - parameter.io
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Lelezard
PharmaCyte Biotech, Inc. (PMCB) 17.97% in Intraday Trading: Success in Monetization Bolsters Financial Position - Stocks Telegraph
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):